Prosena explain Exon Skipping in Duchenne Muscular Dystrophy at 6th annual RNA Therapeutics Summit
RNA Therapeutics, 16th & 17th February, London UK LONDON, LONDON, UNITED KINGDOM, November 27, 2014 /EINPresswire.com/ -- It was announced earlier this week that US Drug maker BioMarin will acquire biopharmaceutical company Prosensa, for a total of $ …